"ChatGPT responses can sound a lot like a human and can be quite...
Category:
Health
Latest
India’s aviation watchdog reviewing fatigue data after pilot death
The rare review, which has not previously been reported, comes...
Medi Assist files IPO papers with Sebi again; public issue entirely an OFS
According to the fresh draft red herring prospectus (DRHP) filed on...
Govt notifies draft rules for hiking FDI to 74 % in insurance sector
According to the draft rules, in an Indian insurance company having foreign investment exceeding 49 per cent not less than fifty per cent. of the net profit for the financial year have to be retained in general reserve, if the insurer’s solvency margin is less than 1.2 times the control level of solvency for a financial year for which dividend is paid on equity shares.
Not less than fifty per cent. of directors of such insurers will be independent directors, unless the chairperson of its board is an independent director, in which case at least one-third of its board shall comprise of independent directors.
3rd vax dose likely needed within 12 months: Pfizer CEO
“A likely scenario is that there will be likely a need for a third dose, somewhere between six and 12 months and then from there, there will be an annual re-vaccination, but all of that needs to be confirmed. And again, the variants will play a key role,” Pfizer Chief Executive Officer Albert Bourla said.
Health ministry issues regulatory pathways for foreign-produced Covid-19 vaccines
The first 100 beneficiaries of such vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further Vaccination programme.
“Applicant shall initiate conduct of post-approval bridging clinical trials within 30 days of such approval,” it said.
Rare blood clotting risk more for Covid-19 than for vaccines: Oxford study
“There are concerns about possible associations between vaccines, and cerebral venous thrombosis (CVT), causing governments and regulators to restrict the use of certain vaccines,” said Paul Harrison, Head of the Translational Neurobiology Group at the University of Oxford.
“Yet, one key question remained unknown: What is the risk of CVT following a diagnosis of Covid-19?” Harrison said.
Study reveals glaucoma may be more than eye pressure issue
According to the National Glaucoma Foundation, over 3 million Americans have glaucoma, but only half know they actually have it. In the US, more than 120,000 individuals are blind from the disease. In addition, the World Health Organisation (WHO) estimates that over 60 million individuals suffer from glaucoma worldwide.
Processed meats, sugary drinks linked to gut inflammation
Eating plant-based foods such as nuts, fruit, vegetables, cereals, and oily fish and red wine was linked to a higher abundance of Faecalibacterium sp, which produce short chain fatty acids that help control inflammation and protect the integrity of the cells lining the gut.
Drug-resistant malaria gaining foothold in Africa: study
There are an estimated 229 million cases of malaria worldwide, according to the World Health Organisation (WHO).
The disease killed more than 400,000 people in 2019, more than two-thirds of them children.
Study reveals unhealthy lifestyle only explains small part of health inequity in UK, US adults
It is well known that disadvantaged socioeconomic status (the measure of a person’s social and economic standing) and unhealthy lifestyles are linked to poor health.
Vaccination not shield against COVID, can reduce severity, lower fatality: Experts
From Delhi to Chennai and even in tier-2 cities like Patna, cases of vaccination beneficiaries contracting the coronavirus infection have been reported in the last couple of months.
EU regulators set July 27 deadline for deadline on Aon, Willis deal
Aon, which announced the deal a year ago to create the world’s largest insurance broker ahead of world No. 1 Marsh & McLennan Companies Inc, offered last Friday to sell assets in five European nations to resolve EU competition concerns.
The EU antitrust watchdog is now seeking feedback from rivals and customers before deciding whether to demand more concessions, clear or block the deal.